Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: An immunohistochemical study

Acta Histochemica

Volumn 113, Issue 6, 2011, Pages 626-630

  Zhang, Mengjun ^a   Sun, Xicai ^a   Yu, Huapeng ^a   Hu, Li ^a   Wang, Dehui ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hemangioma; Histopathology; Human tumors; Immunohistochemistry; Juvenile nasopharygeal angiofibroma; Vascular malformation

Indexed keywords

CD34 ANTIGEN; CYCLINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CAVERNOUS HEMANGIOMA; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; JUVENILE NASOPHARYNX FIBROMA; MICROVASCULATURE; NASOPHARYNX FIBROMA; ORBITAL CAVERNOUS HEMANGIOMA; PROTEIN LOCALIZATION; STROMA CELL;

ADOLESCENT; ADULT; ANGIOFIBROMA; ANTIGENS, CD34; BIOLOGICAL MARKERS; CHILD; ENDOTHELIAL CELLS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, VASCULAR TISSUE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79957927461     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2010.07.003     Document Type: Article

References (18)

1. Beham A., Beham-Schmid C., Regauer S., Auböck L., Stammberger H. Nasopharyngeal angiofibroma: true neoplasm or vascular malformation?. Adv Anat Pathol 2000, 7:36-46.
2. Beham A., Kainz J., Stammberger H., Auböck L., Beham-Schmid C. Immunohistochemical and electron microscopical characterization of stromal cells in nasopharyngeal angiofibromas. Eur Arch Otorhinolaryngol 1997, 254:196-199.
3. Beham A., Regauer S., Beham-Schmid C., Kainz J., Stammberger H. Expression of CD34-antigen in nasopharyngeal angiofibromas. Int J Pediatr Otorhinolaryngol 1998, 1(44):245-250.
4. Beranek J.T., Masseyeff R. Hyperplastic capillaries and their possible involvement in the pathogenesis of fibrosis. Histopathology 1986, 10:543-551.
5. Beranek J.T. Nasopharyngeal angiofibroma revisited. Laryngoscope 1990, 100:791-792.
6. Brieger J., Wierzbicka M., Sokolov M., Roth Y., Szyfter W., Mann W.J. Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas. Arch Otolaryngol Head Neck Surg 2004, 130:727-731.
7. Chang J., Most D., Bresnick S., Mehrara B., Steinbrech D.S., Reinisch J., et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 1999, 103:1-9. discussion 10.
8. Coutinho-Camillo C.M., Brentani M.M., Nagai M.A. Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck 2008, 30:390-400.
9. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995, 28(333):1757-1763.
10. Liang J., Yi Z., Lianq P. The nature of juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 2000, 123:475-481.
11. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69:412-422.
12. Ngan B.Y., Forte V., Campisi P. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy. Arch Otolaryngol Head Neck Surg 2008, 134:1170-1176.
13. Roberts D.M., Kearney J.B., Johnson J.H., Rosenberg M.P., Kumar R., Bautch V.L. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol 2004, 164:1531-1535.
14. Saylam G., Yücel O.T., Sungur A., Onerci M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 2006, 70:227-234.
15. Schuon R., Brieger J., Heinrich U.R., Roth Y., Szyfter W., Mann W.J. Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 2007, 264:389-394.
16. Takahashi K., Mulliken J.B., Kozakewich H.P., Rogers R.A., Folkman J., Ezekowitz R.A. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994, 93:2357-2364.
17. Wendler O., Schäfer R., Schick B. Mast cells and T-lymphocytes in juvenile angiofibromas. Eur Arch Otorhinolaryngol 2007, 264:769-775.
18. Zhang P.J., Weber R., Liang H.H., Pasha T.L., LiVolsi V.A. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. Arch Pathol Lab Med 2003, 127:1480-1484.